关于我们
关于森香生物
专注精密发酵与生物活性原料研发，赋能全球大健康品牌。
始于2015年的精密发酵先驱
森香生物（Morika Bio）是一家总部位于中国青岛的生物科技企业，专注于精密发酵与生物活性原料的研发。依托强大的研发实力，我们为全球领先的营养、大健康及护肤品牌提供无内毒素、高纯度的核心原料。
我们专有的精密发酵平台彻底消除了传统大肠杆菌发酵固有的内毒素风险，为新一代功能性原料树立了更高的安全标准。
使命
让精密生物活性原料在全球大健康领域变得更普及、更安全、更可持续。
愿景
成为全球最受信赖的无内毒素生物活性原料供应商。
Our Journey
Innovation Milestones
A decade of pioneering precision fermentation and redefining bio-active ingredient safety standards.
Company Founded
Morika Bio established in Qingdao, China, focusing on precision fermentation and bio-active ingredient research and development.
Company Founded
Morika Bio established in Qingdao, China, focusing on precision fermentation and bio-active ingredient research and development.
R&D Platform Development
Launched proprietary AI-assisted synthetic biology platform, accelerating strain screening and product development from lab to commercial scale.
R&D Platform Development
Launched proprietary AI-assisted synthetic biology platform, accelerating strain screening and product development from lab to commercial scale.
HMO Breakthrough — 2'-FL & LNnT
Successfully developed 2'-FL and LNnT via precision yeast fermentation, achieving endotoxin-free production at scale.
HMO Breakthrough — 2'-FL & LNnT
Successfully developed 2'-FL and LNnT via precision yeast fermentation, achieving endotoxin-free production at scale.
First Advanced Manufacturing Award
Recognized as one of China's 'Morning Star' Advanced Manufacturing Enterprises, highlighting our innovation in bio-manufacturing.
First Advanced Manufacturing Award
Recognized as one of China's 'Morning Star' Advanced Manufacturing Enterprises, highlighting our innovation in bio-manufacturing.
National Dairy Innovation Center
Selected as a founding member of the National Dairy Technology Innovation Center Council, reinforcing our role in China's HMO industry.
National Dairy Innovation Center
Selected as a founding member of the National Dairy Technology Innovation Center Council, reinforcing our role in China's HMO industry.
Global Expansion Begins
Presented HMO product lines at the 2022 World Advanced Manufacturing Conference. Began serving international nutrition and wellness brands.
Global Expansion Begins
Presented HMO product lines at the 2022 World Advanced Manufacturing Conference. Began serving international nutrition and wellness brands.
LNTr II Milestone — First FDA GRAS Globally
Achieved the world's first FDA GRAS notification for LNTr II (Lacto-N-Triose II), setting a new safety and regulatory benchmark for next-generation HMOs.
LNTr II Milestone — First FDA GRAS Globally
Achieved the world's first FDA GRAS notification for LNTr II (Lacto-N-Triose II), setting a new safety and regulatory benchmark for next-generation HMOs.
Full Product Portfolio Launched
Expanded to 7 HMO variants, marine bio-peptides, and salidroside product lines. Achieved FSSC 22000, ISO 9001, Halal, GMP, and EU Novel Food certifications.
Full Product Portfolio Launched
Expanded to 7 HMO variants, marine bio-peptides, and salidroside product lines. Achieved FSSC 22000, ISO 9001, Halal, GMP, and EU Novel Food certifications.
50+ Countries Served
Products distributed to nutrition, wellness, and skincare brands across 50+ countries. Maintained 110+ global patents in biosynthesis.
50+ Countries Served
Products distributed to nutrition, wellness, and skincare brands across 50+ countries. Maintained 110+ global patents in biosynthesis.
Morika Bio Global Launch
Launched the Morika Bio brand for international markets, built on the 3rd-Gen Precision Yeast Synthesis platform — delivering endotoxin-free, pharmaceutical-grade bio-active ingredients worldwide.
Morika Bio Global Launch
Launched the Morika Bio brand for international markets, built on the 3rd-Gen Precision Yeast Synthesis platform — delivering endotoxin-free, pharmaceutical-grade bio-active ingredients worldwide.